Therefore, while the administration of exogenous human CRP to rodents has afforded essential insights regarding CRP biology, it does not allow for in vivo mechanistic studies of CRP in chronic inflammatory conditions such as IRI, transplant rejection, atherosclerosis, or AMD. Here, CRP is linked to atherosclerosis.